Armstrong RB, Lesiewicz J, Harvey G Clinical panel assessment of photodamaged skin treated with isotretinoin using photographs. Arch Dermatol. 1992; 128:(3)352-356
Baumann L. Cosmetic dermatology and medicine: principles and practice, 2nd edn. New York, NY: McGraw-Hill; 2009
Burke BM, Cunliffe WJ. The assessment of acne vulgaris—the Leeds technique. Br J Dermatol. 1984a; 111:(1)83-92
Chandraratna RA. Tazarotene—first of a new generation of receptor-selective retinoids. Br J Dermatol. 1996; 135:18-25
Cosmetic dermatology: products and procedures, 2nd edn. In: Draelos ZK (editor). Chichester: John Wiley & Sons; 2016
Edward M, Gold JA, MacKie RM. Different susceptibilities of melanoma cells to retinoic acid-induced changes in melanotic expression. Biochem Biophys Res Commun. 1988; 155:(2)773-778
Fisher GJ, Datta SC, Talwar HS Molecular basis of sun-induced premature skin ageing and retinoid antagonism.
Nature. 1996; 379:(6563)335-339
https://doi.org/10.1038/379335a0
Fluhr JW, Vienne MP, Lauze C Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions.
Dermatology (Basel). 1999; 199:57-60
https://doi.org/10.1159/000051381
Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid.
Nature. 1987; 330:(6149)624-629
https://doi.org/10.1038/330624a0
Griffiths CE, Finkel LJ, Tranfaglia MG An in vivo experimental model for effects of topical retinoic acid in human skin. Br J Dermatol. 1993; 129:(4)389-394
Griffiths CE, Kang S, Ellis CN Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol. 1995; 131:(9)1037-1044
Hoal E, Wilson EL, Dowdle EB. Variable effects of retinoids on two pigmenting human melanoma cell lines. Cancer Res. 1982; 42:(12)5191-5195
Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet. 1993; 341:(8854)1181-1182
Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol. 2000; 43:(2 Pt 3)S51-54
Kang S, Duell EA, Fisher GJ Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol. 1995; 105:(4)549-556
Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin: therapy, pathogenesis, and prevention. Arch Dermatol. 1997; 133:(10)1280-1284
Kaya G, Saurat J-H. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments.
Dermatol (Basel). 2007; 215:(4)284-294
https://doi.org/10.1159/000107621
Kim B-H, Lee Y-S, Kang K-S. The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett. 2003; 146:(1)65-73
Kligman AM. The growing importance of topical retinoids in clinical dermatology: a retrospective and prospective analysis. J Am Acad Dermatol. 1998; 39:(2 Pt 3)S2-7
Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986; 15:(4 Pt 2)836-859
Kligman LH, Duo CH, Kligman AM. Topical retinoic acid enhances the repair of ultraviolet damaged dermal connective tissue. Connect Tissue Res. 1984; 12:(2)139-150
Kurlandsky SB, Xiao JH, Duell EA Biological activity of all-trans retinol requires metabolic conversion to all-trans retinoic acid and is mediated through activation of nuclear retinoid receptors in human keratinocytes. J Biol Chem. 1994; 269:(52)32821-32827
Levin J, Momin SB. How much do we really know about our favorite cosmeceutical ingredients?. J Clin Aesthet Dermatol. 2010; 3:(2)22-41
Ligade VS, Sreedhar D, Manthan J, Udupa N. Cosmeceuticals: are they truly worth the cost?. Indian J Dermatol Venereol Leprol. 2009; 75:(1)8-9
Lockman PR, Mumper RJ, Khan MA, Allen DD. Nanoparticle technology for drug delivery across the blood-brain barrier.
Drug Dev Ind Pharm. 2002; 28:(1)1-13
https://doi.org/10.1081/DDC-120001481
Lowe N, Gifford M, Tanghetti E Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
J Cosmet Laser Ther. 2004; 6:(2)79-85
https://doi.org/10.1080/14764170410032406
Maddin S, Lauharanta J, Agache P Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial.
J Am Acad Dermatol. 2000; 42:(1)56-63
https://doi.org/10.1016/S0190-9622(00)90009-4
McDaniel DH, Mazur C, Wortzman MS, Nelson DB. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging.
J Cosmet Dermatol. 2017; 16:(4)542-548
https://doi.org/10.1111/jocd.12381
Mukherjee S, Date A, Patravale V Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006; 1:(4)327-348
Nagpal S, Athanikar J, Chandraratna RA. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J Biol Chem. 1995; 270:(2)923-927
Oda RM, Shimizu RW, Sabatine SC 1996. Effects of structural changes on retinoid cytotoxity in the CHO clonal assay. In vitro Toxicol. 9:173-81
Pechère M, Germanier L, Siegenthaler G The antibacterial activity of topical retinoids: the case of retinaldehyde.
Dermatology (Basel). 2002; 205:(2)153-158
https://doi.org/10.1159/000063903
Pechère M, Pechère JC, Siegenthaler G Antibacterial activity of retinaldehyde against Propionibacterium acnes.
Dermatology (Basel). 1999; 199:29-31
https://doi.org/10.1159/000051375
Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors.
Nature. 1987; 330:(6147)444-450
https://doi.org/10.1038/330444a0
Sendagorta E, Lesiewicz J, Armstrong RB. Topical isotretinoin for photodamaged skin. J Am Acad Dermatol. 1992; 27:(6 Pt 2)S15-18
Singh DK, Lippman SM. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology (Williston Park, NY). 1998; 12:(11)1643-1653
Sorg O, Tran C, Saurat JH. Cutaneous vitamins A and E in the context of ultraviolet-or chemically-induced oxidative stress.
Skin Pharmacol Appl Skin Physiol. 2001; 14:(6)363-372
https://doi.org/10.1159/000056370
Stüttgen G. Historical perspectives of tretinoin. J Am Acad Dermatol. 1986; 15:(4 Pt 2)735-740
Tesoriere L, D'Arpa D, Re R, Livrea MA. Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration.
Arch Biochem Biophys. 1997; 343:(1)13-18
https://doi.org/10.1006/abbi.1997.0128
Tsuchiya M, Scita G, Freisleben HJ Antioxidant radicalscavenging activity of carotenoids and retinoids compared to alpha-tocopherol. Meth Enzymol. 1992; 213:460-472
Verschoore M, Bouclier M, Czernielewski J, Hensby C. Topical retinoids. Their uses in dermatology. Dermatol Clin. 1993; 11:(1)107-115
Verschoore M, Poncet M, Czernielewski J Adapalene 0.1% gel has low skin-irritation potential. J Am Acad Dermatol. 1997; 36:(6 Pt 2)S104-109
Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release. 2002; 81:(3)225-233
Yamaguchi Y, Nagasawa T, Nakamura N Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery.
J Control Release. 2005; 104:(1)29-40
https://doi.org/10.1016/j.jconrel.2004.11.036